Navigation Links
Nutrition research unveiled this week shows pistachios are smart for the heart
Date:4/8/2008

ddition to cholesterol measures (lipids and lipoproteins), blood pressure, heart rate, stroke volume, cardiac output and total resistance to blood flow through the vascular arteries were measured. At the end of each study period, cells were isolated from all subjects and genetic expression of inflammation markers was measured.

Study Highlights

Study results demonstrate the beneficial effects of a diet rich in pistachios on multiple CVD risk factors. As indicated in a previous release of this study, cholesterol levels, a prominent risk factor for CVD, improved with pistachio consumption. Compared to baseline, both the 1.5 and 3.0 ounce pistachio diets resulted in reduction of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C). In addition to the beneficial effects of pistachios on cholesterol, including pistachios as part of a heart-healthy diet also significantly reduced inflammation at the cellular level.

"Reducing inflammation at the cellular level is an important finding as it may be a more specific marker of inflammatory status than blood markers, which are general indicators of inflammation in the body," said Dr. Sarah Gebauer, Penn State University. "We are truly excited about these results and what they mean for those at risk for cardiovascular disease."

As an organization dedicated to promoting nutrition news about pistachios and health, the WPA is already planning to fund additional research at Penn State and the University of Toronto, continued Dr. Geiger. We hope to learn more about the effects of pistachios on blood pressure in people with diabetes and the effects of pistachios on satiety hormones and hormones that regulate blood sugar.

Pistachios Pack Powerful Nutrition

In July 2003, the U.S. FDA announced that eating most nuts, such as pistachios, may help reduce the risk of heart disease when eaten as part of a diet low in saturated fat and cholesterol. Since then, the U.S. pi
'/>"/>

Contact: A'ndrea Elyse Messer
Aem1@psu.edu
814-865-9481
Henson Consulting, Inc.
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. New way to produce high-vitamin corn could improve nutrition in developing countries
2. Scientists study the link between childrens nutrition and adult diseases
3. For nutrition info, moms like the Web best
4. U of I scientist does nutritional detective work in Botswana
5. 3 out of 4 hospital patients suffer from malnutrition regardless of their pathology
6. Leading experts cite poor health and nutrition as major barrier to education in developing world
7. Purdue researchers click nutrition with camera diet study
8. Death protein research secures funding for UCF scientists
9. War between the sexes begins before twins birth, TAU researchers say
10. Researchers see structure of open nicotinic acetylcholine ion channels
11. Reflecting on the social implications of human genetics research -- past, present and future
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6